Figure 1From: Distinct signatures of the immune responses in low risk versus high risk neuroblastomaDifferential gene expression profile in tumor lesions of patients with HR vs. LR neuroblastoma. A) Unsupervised cluster analysis of LR vs. HR patients. B) Supervised cluster analysis (Student t test, p < 0.01 and fold change > 3) comparing LR vs. HR. C) Canonical pathway analysis shows the significant genes and pathways that differ between HR and LR neuroblastoma.Back to article page